Skip to Main Content

Paper Details

Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study.
59
2023
COVID-19, Covid-19, Nirmatrelvir, Patients, Ritonavir, SARS, SARS-CoV-2, immune, immune-evasive, nirmatrelvir, patients, ritonavir
Author NameAffiliation
Arthur Y KimMassachusetts General Hospital
Rajesh T GandhiMassachusetts General Hospital
  • 1 - 2

Datasets

Release 1.2